UCSF at the “ARVO 2024 Annual Meeting”

UCSF Ophthalmology and Proctor Foundation faculty, along with their research teams, are gearing up for the Association for Research in Vision and Ophthalmology (ARVO) annual meeting, scheduled from May 5th to May 9th, 2024, in Seattle, Washington. Their insightful presentations and contributions for this event are outlined below.

Faculty and Alumni, please join us for our cocktail reception at Metropolitan Grill, 820 Second Avenue in Seattle on Tuesday, May 7th, 2024 from 6:00 – 8:00pm. Please RSVP by the end of the day, Monday, April 22nd to Shelagh Stewart-Chung at shelagh.stewart-chung@ucsf.edu

Faculty and Student Presentations and Contributions

Saturday, May 04

Matilda Chan, MD, PhD

Welcome and overview of the Peer-Review Process

Date: 5/4/2024, Time (PST): 08:00 AM

Location: Exhibit Hall – Seattle Convention Center

Type: ARVO Education Course

Session: Journal Peer Review Fundamentals


Sunday, May 05

Nailyn Rasool, MD

Neuroradiology for the ophthalmology resident: Evaluation of a self-directed online curriculum.

Date: 5/5/2024, Time (PST): 08:00 AM

Location: Exhibit Hall – Seattle Convention Center

Type: Poster, A0301

Poster Range: A0301

Session: A0301: Neuroradiology for the ophthalmology resident: Evaluation of a self-directed online curriculum.


Elana Meer, MD, MBA

AMD Injection Frequency: Effects of Distance Traveled and Travel Support

Date: 5/5/2024, Time (PST): 08:00 AM

Location: Exhibit Hall – Seattle Convention Center

Type: Poster, 229-B0292

Poster Range: B0292

Session: AMD-1 (anti-VEGF)


Valencia Fernandes, PhD

Mechanism and Consequences of Intracellular C3 activation in the Retinal Pigment Epithelium in Models of Macular Degeneration

Date: 5/5/2024, Time (PST): 01:00 PM

Location: Exhibit Hall – Seattle Convention Center

Type: Poster,767 Session # 135

Poster Range: B0268

Session: AMD: Mechanisms and preclinical studies

Mentor: Aparna Lakkaraju,PhD


Abu Tahir Taha, BS

Flow characterization of Ahmed glaucoma FP7 tubes after in-vitro aging in silicone oil

Date: 5/5/2024, Time (PST): 01:00 PM

Location: Exhibit Hall – Seattle Convention Center

Type: Poster, 797

Poster Range: B0386

Session: Retina miscellaneous 1

Mentor: Frank Brodie, MD


Linus Shen, MD

Longitudinal Change in Cone Structure and Retinal Sensitivity in Choroideremia

Date: 5/5/2024, Time (PST): 01:30 PM

Location: Exhibit Hall – Seattle Convention Center

Type: Presentation Number: 405

Session: Retina miscellaneous: Translational

Mentor: Jacque Duncan, MD


David G. Hwang, MD

A0126: Does Placing a Glaucoma Tube Shunt Farther Away From the Cornea Increase Endothelial Keratoplasty Survival?

Date: 5/5/2024, Time (PST): 03:15 PM

Location: Exhibit Hall – Seattle Convention Center

Type: Poster, A0126

Poster Range: A0114 – A0165

Session: Corneal surgery


Veronika Karlegan, MS

Impact of a High-Volume, Dedicated Strabismus Screening Clinic on Pediatric Ophthalmology Referrals and Access to Care

Date: 5/5/2024, Time (PST): 03:15 PM

Location: Exhibit Hall – Seattle Convention Center

Type: Poster, A0351

Poster Range: A0351 – A0385

Session: Strabismus

Mentor: Maanasa Indaram, MD, Julius Oatts, MD, & Alejandra de Alba Campomanes, MD


Yvonne Ou, MD

Synaptic remodeling and glaucoma

Date: 5/5/2024, Time (PST): 03:52 PM

Location: Exhibit Hall – Seattle Convention Center

Type: Presentation Number: 1033

Session: Beyond the Bottleneck: Nonaxonal signaling mechanisms in glaucoma and new approaches to neuroprotection


Ou, Yvonne MD

Survival and integration of organoid derived iPSC-RGCs into NHP tissue in an organotypic retinal explant culture system

Date: 5/5/2024, Time (PST): 04:15 PM

Location: Exhibit Hall – Seattle Convention Center

Type: Presentation Number: 952

Session: Advances in stem cell and organoid models of retinal development and disease


Xin Duan, PhD

Osteopontin drives retinal ganglion cell resiliency in glaucomatous optic neuropathy

Date: 5/5/2024, Time (PST): 04:25 PM

Location: Exhibit Hall – Seattle Convention Center

Type: Presentation Number: 1035

Session: Beyond the bottleneck: Nonaxonal signaling mechanisms in glaucoma and new approaches to neuroprotection


Monday, May 06

Bamadeb Patra, PhD

MANF modulates retinal immune microenvironment to suppress inflammation

Date: 5/6/2024, Time (PST): 08:30 AM

Location: Exhibit Hall – Seattle Convention Center

Type: Poster, 1683-B0002

Poster Range: 1683 – B0002

Session: Poster Session-Retinal Cell Biology

Mentor: Deepak Lamba, PhD & Erik Ullian, PhD


Stephanie Zhang, MD

Association of OCT angiography (OCTA) parameters with age as modified by diabetes status.

Date: 5/6/2024, Time (PST): 08:30 AM

Location: Exhibit Hall – Seattle Convention Center

Type: Poster, B0088

Poster Range: B0088

Session: Diabetic retinopathy I

Mentor: Jay Stewart, MD


Marycon Jiro

B0178: Analysis of Associated Factors with Legal Blindness at an Urban Safety-Net Hospital

Date: 5/6/2024, Time (PST): 08:30 AM

Location: Exhibit Hall – Seattle Convention Center

Type: Poster, B0178

Poster Range: B0178

Session:

Mentor: Jonathan Li, MD


Douglas Pula, BA

Corneal Nerve Sub-Basal Nerve Metrics: Insights from the Sjögren’s International Collaborative Clinical Alliance

Date: 5/6/2024, Time (PST): 08:30 AM

Location: Exhibit Hall – Seattle Convention Center

Type: Poster, B0462

Poster Range: B0451 – B0499

Session: Corneal imaging and biomechanics

Mentor: John Gonzales, MD


Alejandro Arboleda, MD, MS

Practice Patterns in the Management of Aphakia in the Absence of Capsular Support

Date: 5/6/2024, Time (PST): 08:30 AM

Location: Exhibit Hall – Seattle Convention Center

Type: Abstract Number: 2078 – B0603

Poster Range: B0603

Session: Cataract surgery: Treatments and techniques

Mentor: Frank Brodie, MD, & Julie Schallhornm, MD MS


Elana Meer, MD, MBA

Perceptions of Exposure to New Technology in Residents and Practicing Ophthalmologists

Date: 5/6/2024, Time (PST): 08:30 AM

Location: Exhibit Hall – Seattle Convention Center

Type: Abstract Number: 2091 – B0616

Poster Range: B0616

Session: Cataract surgery: Treatments and techniques

Mentor: Frank Brodie, MD, & Julie Schallhornm, MD MS


Jacque Duncan, MD

Static Perimetry Results

Date: 5/6/2024, Time (PST): 1:26:00 PM

Location: 6E – Seattle Convention Center – Arch Building

Type: Presentation

Session: RUSH2A natural history study: 4 year progression data and implications for future trial design


Chu Jian Ma, MD, PhD

Comparison of Diagnosis Codes to Clinical Notes in Classifying Neovascular Glaucoma Patients

Date: 5/6/2024, Time (PST): 03:00 PM

Location: Exhibit Hall – Seattle Convention Center

Type: Poster, A0314

Poster Range: A0314

Session:

Mentor: Catherine Sun, MD


Lyndon Jones, PhD

AZR-MD-001 Opens Meibomian Glands, Improves Meibum and Tear Quality Resulting in Increased Wear Time and Desired Lens Use in Patients With CLD

Date: 5/6/2024, Time (PST): 03:00 PM

Location: Exhibit Hall – Seattle Convention Center

Type: Poster, B0513

Poster Range: B0513

Session: Cornea


Yvonne Ou, MD

Inner retinal wiring

Date: 5/6/2024, Time (PST): 03:50 PM

Location: Exhibit Hall – Seattle Convention Center

Type: Presentation Number: 2111

Session: A roadmap for developing vision-restoring therapies for patients suffering from optic neuropathy


Tuesday, May 07

Emmanuel Agu, BS

The distribution of trachoma across communities in Malawi, Mozambique, and Tanzania characterizes progress towards elimination and the probability of transmission hotspots

Date: 5/7/2024, Time (PST): 08:30 AM

Location: Exhibit Hall – Seattle Convention Center

Type: Poster, A0007

Poster Range: A0007

Session: Anterior segment, ocular trauma and surgery – Epidemiology

Mentor: Thomas Lietman, MD


Fanxiu Xiong, MBBS, MPH

Predictors of Discordance between Dry Eye Symptoms and Signs: Insights from the Sjögren’s International Collaborative Clinical Alliance

Date: 5/7/2024, Time (PST): 08:30 AM

Location: Exhibit Hall – Seattle Convention Center

Type: Poster, 2933 – A0092

Poster Range: 2933 – A0092

Session: Dry eye: Clinical aspects

Mentor: John Gonzales, MD


John Gonzales, MD

Identifying novel biomarkers in Sjögren’s disease: insights from the Sjögren’s International Collaborative Clinical Alliance

Date: 5/7/2024, Time (PST): 08:30 AM

Location: Exhibit Hall – Seattle Convention Center

Type: Poster,A0091

Poster Range: A0091

Session: Dry eye: clinical aspects


Yvonne Ou, MD

A deep learning approach for automated synapse detection in animal models of retinal neurodegeneration

Date: 5/7/2024, Time (PST): 09:45 AM

Location: Exhibit Hall – Seattle Convention Center

Type: Presentation Number: 2773

Session: AI in the retina


Wenhao Shang, PhD

Characterization of chorioretinal anastomosis, neovascularization, and blood flow in Col4a1 mutant mice using multiphoton microscopy and computational analysis

Date: 5/7/2024, Time (PST): 01:15 PM

Location: Exhibit Hall – Seattle Convention Center

Type: Poster, A0266

Poster Range: A0266

Session: Visual Psychophysics/Physiological Optics

Mentor: Tyson Kim, MD


Rongshan Yan, PhD

Calcium-Sensing Receptor (CaSR) Inhibitor NPS-2143 Increases Ocular Surface Hydration
for Treatment of Dry Eye Disease

Date: 5/7/2024, Time (PST): 01:15 PM

Location: Exhibit Hall – Seattle Convention Center

Type: Poster,B0263

Poster Range: B0250 – B0273

Session: Intraocular pressure, corneal disease, and ocular toxicology

Mentor: Onur Cil, MD, PhD & Neel Pasricha, MD


David G. Hwang, MD

B0364: Borderline trachoma cases can be identified with a non-dichotomous latent class analysis (LCA)

Date: 5/7/2024, Time (PST): 01:15 PM

Location: Exhibit Hall – Seattle Convention Center

Type: Poster, B0364

Poster Range: B0310 – B0369

Session: Cornea: Other


Bole Ying, no degree

Machine Learning Models for Predicting Cycloplegic Refractive Error and Myopia Status Based on Non-Cycloplegic Data in Chinese Students

Date: 5/7/2024, Time (PST): 01:15 PM

Location: Exhibit Hall – Seattle Convention Center

Type: Poster, B0387

Poster Range: B0387

Session: AI in Epidemiology and clinical research

Mentor: Julius Oatts, MD


Jonathan Hwang, no degree

Borderline trachoma cases can be identified with a non-dichotomous latent class analysis (LCA)

Date: 5/7/2024, Time (PST): 03:00 PM

Location: Exhibit Hall – Seattle Convention Center

Type: Poster, B0364

Poster Range: B0364

Session: Poster Session

Mentor: Tom Lietman, MD


Wednesday, May 08

Sydney Williams

Membrane trafficking defects compromise the structural integrity of the RPE in Stargardt disease

Date: 5/8/2024, Time (PST): 10:30 AM

Location: Exhibit Hall – Seattle Convention Center

Type: Poster, B0298

Poster Range: B0295 – B0358

Session: photoreceptor development and degeneration

Mentor: Aparna Lakkaraju, PhD


Anika Kumar, BA

Diagnostic performance of a handheld electroretinography test for glaucoma

Date: 5/8/2024, Time (PST): 10:30 AM

Location: Exhibit Hall – Seattle Convention Center

Type: Poster, B0444

Poster Range: B0436 – B0487

Session: Functional testing and visual fields

Mentor: Yvonne Ou, MD


Irene Pak, BS

Feasibility of Low-Fatigue Virtual Reality Visual Field Testing for Non-English Speaking Patients at a County Hospital

Date: 5/8/2024, Time (PST): 10:30 AM

Location: Exhibit Hall – Seattle Convention Center

Type: Poster, B0481

Poster Range: B0436-B0487

Session: Functional testing and visual fields

Mentor: Yvonne Ou, MD


Albert Xu, BA

Evaluating ON and OFF pathways in glaucoma with virtual reality-based perimetry

Date: 5/8/2024, Time (PST): 10:30 AM

Location: Exhibit Hall – Seattle Convention Center

Type: Poster, B4782 – B0445

Poster Range: B4782 – B0445

Session: Functional testing and visual fields

Mentor: Yvonne Ou MD


Kenichi Toma, PhD

Perivascular Neurons Instruct Three-Dimensional Retinal Vascular Lattice Formation via Direct Neurovascular Contact

Date: 5/8/2024, Time (PST): 11:00 AM

Location: Exhibit Hall – Seattle Convention Center

Type: Presentation Number: 4348

Session: RGCs and retinal output

Mentor: Xin Duan, PhD


O’Rese J. Knight, MD

A0433: Optimization of Atomic Force Microscopy Cantilever Specifications for Introcular Pressure Measurement

Date: 5/8/2024, Time (PST): 02:15 PM

Location: Exhibit Hall – Seattle Convention Center

Type: Poster, A0433

Poster Range: A0428 – A0449

Session: Outflow pathway and aqueous humor dynamics II


Tessnim Ahmad, MD

Three-year Outcomes of Pediatric Keratoconus Patients Treated with Corneal Collagen Crosslinking under General Anesthesia

Date: 5/8/2024, Time (PST): 02:15 PM

Location: Exhibit Hall – Seattle Convention Center

Type: Poster, B0051

Poster Range: B0043 – B0065

Session: Pediatric ophthalmology

Mentor: Maanasa Indaram, MD & Neel Pasricha, MD


Marinia Bishay, BS

Temporal and Seasonal Trends in Pediatric Eye Trauma in California

Date: 5/8/2024, Time (PST): 02:15 PM

Location: Exhibit Hall – Seattle Convention Center

Type: Poster B0052

Poster Range: B0052

Session: Pediatric Ophthalmology

Mentor: Julius Oatts, MD


Alan Pham, BS

Enhancing User Experience with 3D Printed Glasses for Patients with Craniofacial Anomalies Using a Human-Centered Design Approach.

Date: 5/8/2024, Time (PST): 02:15 PM

Location: Exhibit Hall – Seattle Convention Center

Type: Poster, 5228 – B0056

Poster Range: B0056

Session: Pediatric Ophthalmology

Mentor: Frank Brodie, MD


Julius Oatts, MD

Pediatric Eye-Related Emergency Room Visits and Pediatric Eye Provider Location

Date: 5/8/2024, Time (PST): 02:15 PM

Location: Exhibit Hall – Seattle Convention Center

Type: Poster, B0074

Poster Range: B0074

Session: Pediatric Ophthalmology and inherited eye diseases


Jalin Jordan, BA

Association Between Area Deprivation Index and Retinopathy of Prematurity

Date: 5/8/2024, Time (PST): 02:15 PM

Location: Exhibit Hall – Seattle Convention Center

Type: Poster, B0088

Poster Range: B0088

Session: Pediatric Ophthalmology and inherited eye diseases

Mentor: Julius Oatts, MD


Yiyi Wang, PhD

Impact of Early Intraretinal Fluid Reduction on One-Year Outcomes in Diabetic Macular Edema

Date: 5/8/2024, Time (PST): 03:30 PM

Location: Exhibit Hall – Seattle Convention Center

Type: Presentation Number: 4886

Session: Diabetic macular edema

Mentor: Jacque Duncan, MD


Thursday, May 09

Finn Wolfreys, PhD

Assessing Glafenine and Prostaglandin Synthesis Modulators for the Rescue of Fuchs’ Dystrophy-Associated SLC4A11 Misfolding Mutants by Flow-cytometry

Date: 5/9/2024, Time (PST): 08:00 AM

Location: Exhibit Hall – Seattle Convention Center

Type: Poster, B0360

Poster Range: B0342 – B0380

Session: Corneal endothelium: Dystrophies

Mentor: Matilda Chan, MD, PhD


Elizabeth Hoang, MS

The Spectrum of Visual Impairment and Eye Pathology in a Population Experiencing Housing Insecurity

Date: 5/9/2024, Time (PST): 08:00 AM

Location: Exhibit Hall – Seattle Convention Center

Type: Poster, 5966

Poster Range: B0629

Session: The Spectrum of Visual Impairment and Eye Pathology in a Population Experiencing Housing Insecurity

Mentor: Matilda F. Chan, MD, PhD, Sriranjani Padmanabhan, MD, Kieran O’Brien, PhD, MPH


Xinyi Chen, MD

Factors associated with inflammation-related biomarkers on optical coherence tomography (OCT) in patients with diabetic macular edema (DME)

Date: 5/9/2024, Time (PST): 11:45 AM

Location: Exhibit Hall – Seattle Convention Center

Type: Poster, 6249

Poster Range: B0159

Session: Diabetic macular edema

Mentor: Jay Stewart, MD


Ethan Lindgren, BS

Lysophosphatidic Acid Receptors (LPARs) Regulate Ocular Surface Ion Transport

Date: 5/9/2024, Time (PST): 11:45 AM

Location: Exhibit Hall – Seattle Convention Center

Type: Presentation Number: 6169

Session: Corneal epithelium

Mentor: Neel Pasricha, MD & Onur Cil, MD, PhD


Yao Tong, PhD

Dysregulated exocytosis by the retinal pigment epithelium as a potential mechanism for drusen deposition in age-related macular degeneration

Date: 5/9/2024, Time (PST): 02:00 PM

Location: Exhibit Hall – Seattle Convention Center

Type: Poster, 6723 – B0846

Poster Range: 6723 – B0846

Session: 551

Mentor: Aparna Lakkaraju, PhD


Julie Schallhorn, MD, MS

Sign and Symptom Improvement Rates Among MGD Patients Following Treatment With AZRMD001 for 6 Months

Date: 5/9/2024, Time (PST): 02:00 PM

Location: Exhibit Hall – Seattle Convention Center

Type: Poster, B0269

Poster Range: B0215 – B0279

Session: Tear film, meibomian gland, lacrimal gland


Tara Suresh, BS

Method for Quantitative Evaluation of Posterior Vitreous Adhesion in Ex Vivo Porcine Eyes

Date: 5/9/2024, Time (PST): 02:00 PM

Location: Exhibit Hall – Seattle Convention Center

Type: Poster, 6630 – B0753

Poster Range: B0753

Session: Posterior segment imaging and vitreoretinal interface disease

Mentor: Frank Brodie, MD


Lauren Ong, BA

A Systematic Review of Rheometric Techniques Assessing Vitreous Humour Viscosity

Date: 5/9/2024, Time (PST): 02:00 PM

Location: Exhibit Hall – Seattle Convention Center

Type: Poster, 6643-B0766

Poster Range: B0766

Session: Posterior segment imaging and vitreoretinal interface disease

Mentor: Frank Brodie, MD


Natan Hekmatjah, BS

Visual Field Testing Frequency and Associations in Children with Glaucoma

Date: 5/9/2024, Time (PST): 02:00 PM

Location: Exhibit Hall – Seattle Convention Center

Type: Presentation Number: 6472

Session: Functional testing and visual fields

Mentor: Julius Oatts, MD

 

UCSF’s Center for Gould Syndrome!

A news story featuring how Dr. Douglas Gould’s work lead to the opening of the world’s first center of excellence to help families of children with Gould Syndrome is featured on UCSF’s News!

We are pleased to announce a story about the opening of the First Center of Excellence for Gould Syndrome, featuring our Dr. Douglas Gould and his research efforts leading to this new center to help families with children affected by this rare genetic disorder. This center is also includes pediatric ophthalmologist Dr. Alejandra de Alba Campomanes and is the culmination of years of Dr. Gould’s research group’s translational research work to understand the biological functions of a multi-system disorder that is caused by mutations in the genes encoding type IV collagen alpha 1 (COL4A1) and COL4A2. Dr. Gould is a Professor of Ophthalmology and Anatomy and a member of the Institute for Human Genetics, Bakar Aging Research Institute, and Cardiovascular Research Institute.

Learn more about their research here: https://ophthalmology.ucsf.edu/gouldlab/ and read the exciting full news story here: https://www.ucsf.edu/news/2024/02/427141/ucsf-opens-worlds-first-center-excellence-gould-syndrome 

UCSF at the “AAO 2023 Annual Meeting”

UCSF Ophthalmology and Proctor Foundation Faculty are attending the American Academy of Ophthalmology “AAO 2023” annual meeting in San Francisco, from Friday, November 3rd, 2023 to Monday, November 6th, 2023.  Faculty presentations and contributions for the event are listed below.

The Francis I. Proctor Foundation, the Department of Ophthalmology, the Frederick C. Cordes Eye Society, the H. Bruce Ostler Association of Proctor Fellows, and All May See Foundation will host a cocktail reception to showcase the Wayne and Gladys Valley Center for Vision Saturday, November 4, 2023 from 5:00 – 7:00 pm (1st Floor – South Lobby). We are also planning a tribute to Robert L. Stamper, MD, on the occasion of his retirement from 7:00 -7:30 pm in the Hoffman Auditorium that evening. Please RSVP by October 20 to attend.

 

Faculty Presentations and Contributions


Friday, 11-03-2023


Nailyn Rasool

I Am on Ethambutol—What Should I Look for? (NEU02)

Date: 11-03-2023, Time (PST): 8:43 AM
Location: West 2005 -NEU02
Type: In person Live Broadcast On Demand
Session: Section I: What Meds Is My Patient On? Adverse Reactions of Systemic Medications


John Gonzales

Liquid biospy is positive: no, it’s not lymphoma (PTH02)

Date: 11-03-2023, Time (PST): 8:55 AM
Location: West 2002 – PTH02
Type: In person, On Demand
Session: Ocular Oncology & Pathology


Marc Levin

Older Patient with Vision Loss and Swollen Nerve

Date: 11-03-2023, Time (PST): 10:40 AM
Location: West 2005 – NEU03
Type: In person Live Broadcast On Demand
Session: NEU03: Swollen Optic Nerve II


Catherine Sun

New Frontier in Neovascular Glaucoma

Date: 11-03-2023, Time (PST): 10:50 AM
Location: glaucoma subspecialty day. Esplanade Ballroom – GLA04
Type: In person Live Broadcast On Demand
Session: Section III: Fisherman’s Wharf: Catching Up on New Ideas


Yvonne Ou

Helping Glaucoma Patients at Home With Tools, Such as Nanodropper, iCare HOME2, Home Visual Field

Date: 11-03-2023, Time (PST): 11:18 AM
Location: glaucoma subspecialty day – GLA04
Type: In person
Session: Glaucoma Care at the Golden Gate and Beyond


Ying Han

Non-valve Tube Shunt Surgery

Date: 11-03-2023, Time (PST): 3:30 PM
Location: glaucoma subspecialty day – Esplanade Ballroom GLA06
Type: In person
Session: Glaucoma Care at the Golden Gate and Beyond


Julie Schallhorn

The Demographic Burden of Pediatric Blepharokeratoconjunctivitis

Date: 11-03-2023, Time (PST): 3:30 PM
Location: Poster = PO127
Type: On Demand Only
Session: Cornea, External Disease


Julie Schallhorn

Correlating Corneal, External and Refractive Disorders: Diagnosis and Public Interest

Date: 11-03-2023, Time (PST): 3:30 PM
Location: Poster = PO146
Type: On Demand Only
Session: Cornea, External Disease


Julie Schallhorn

Factors Affecting Patient-Reported Outcomes After Cataract Surgery

Date: 11-03-2023, Time (PST): 3:30 PM
Location: E Poster = RP30075793
Type: On Demand Only
Session: RP30075793


Jessica Shantha

The Milky Way

Date: 11-03-2023, Time (PST): 11:00 AM
“Location: 345 Stockton Street
Grand Ballroom West”
Type: In person
Session: SPEIO


Gerami Seitzman

The Demographic Burden of Pediatric Blepharokeratoconjunctivitis

Date: 11-03-2023, Time (PST): 3:30 PM
Location: Poster = PO127
Type: On Demand Only
Session: Cornea, External Disease


Saturday, 11-04-2023


Nailyn Rasool

Down the Rabbit Hole: What to do when your patient is 20/20 but can’t see well

Date: 11-04-2023, Time (PST): 8:00-9:15 AM
Location: South 304 – 217
Type: In Person
Session: 217


Julie Schallhorn

Section II: Simple Explanation On …… Overview of Topic and Understand Basics

Date: 11-04-2023, Time (PST): 8:00 AM
Location: LAB146A / WEST 3014 – REF03
Type: In Person, Live Broadcast, On Demand
Session: Refractive Surgery


Jessica Shantha

Global Health

Date: 11-04-2023, Time (PST): 10:50 AM
Location: RM 22 North
Type: In person
Session: MOM Program


Julie Schallhorn

Unexplained Vision Loss

Date: 11-04-2023, Time (PST): 12:45 PM
Location: SYM07 / ESPLANADE BALLROOM – SYM07
Type: In Person, Live Broadcast, On Demand
Session: Retina, Vitreous


Jacque Duncan

What’s New in Retinal Degenerations

Date: 11-04-2023, Time (PST): 2:30 PM
Location: retina subspecialty day West 3004 – RET19
Type: In Person Live Broadcast On Demand
Session: Section XVI: Gene and Cell-Based and Neuro-Protection Therapies


Matilda Chan

Instruction course

Date: 11-04-2023, Time (PST): 3:45 PM
Location: West 2020 – Session 287
Type: In person
Session: Effective Peer Review: A Responsibility to Maintain Scientific Integrity


Nailyn Rasool

Curbside Consultation in Neuro-Ophthalmology

Date: 11-04-2023, Time (PST): 3:45-5:00 PM
Location: South 304 – 276
Type: In Person
Session: Curbside Consultation in Neuro-Ophthalmology


Sunday, 11-05-2023


Julie Schallhorn

Special Topics in Uveitis

Date: 11-05-2023, Time (PST): 9:45 AM
Location: SYM30 / WEST 2002 – SYM30
Type: In Person, Live Broadcast, On Demand
Session: Uveitis, Intraocular Inflammation


O’Rese Knight

Glaucoma Care for All: Opportunities and Pitfalls of Artificial Intelligence

Date: 11-05-2023, Time (PST): 9:45 AM
Location: SYM29 / WEST 2005
Type: In Person, On Demand
Session: Glaucoma


Gerami Seitzman

Plasminogen Deficiency: Multi-Organ Disease with Ophthalmic Manifestations

Date: 11-05-2023, Time (PST): 11:10 AM
Location: North Expo 5302
Type: in person
Session:


Julie Schallhorn

Advanced Endothelial Keratoplasty (DSEK/DMEK): Overview and Surgical Pearls

Date: 11-05-2023, Time (PST): 1:00 PM
Location: LAB122A / SOUTH 4
Type: In Person Only
Session: Cornea, External Disease


Jonathan Li

Instruction course

Date: 11-05-2023, Time (PST): 2:00PM – 3:15PM
Location: SOUTH 203-204 – 471
Type: In Person
Session: Myopia Management: Global Perspectives, Digital Innovation and Artificial Intelligence


Charlene Choo (Mentor: Jessica Shantha)

Ophthalmic Sequelae of Ebola Virus Disease in Survivors from Sierra Leone

Date: 11-05-2023, Time (PST): 2:12 PM
Location: West 2006 – OP08/PA044
Type: Oral/paper
Session: Uveitis Original Papers


Alejandra de Alba

Treatment Options for Convergence Insufficiency Exotropia

Date: 11-05-2023, Time (PST): 2:22 PM
Location: WEST 2005 – SYM44
Type: In person, on Demand
Session: Adult Strabismus for the Comprehensive Ophthalmologist


Julie Schallhorn

Laser Surgery and Imaging for Corneal Diseases: When and How

Date: 11-05-2023, Time (PST): 3:45 PM
Location: WEST 2002 – SYM52
Type: In Person, Live Broadcast, On Demand
Session: Cornea, External Disease


Jessica Shantha

Celebrating Global Ophthalmology: Champions of Change and Challenges Ahead

Date: 11-05-2023, Time (PST): 2:00 PM
Location: SYM63
Type: In person, on demand
Session: Celebrating Global Ophthalmology: Champions of Change and Challenges Ahead


Monday, 11-06-2023


Gerami Seitzman

Acanthamoebal Infections

Date: 11-06-2023, Time (PST): 11:40 AM
Location: WEST 2005 -SYM62
Type: In Person, On Demand
Session: Latest Diagnostic and Therapeutic Advancements in Ocular Infections

Retinal Regeneration

AUDACIOUS GOALS

What if individuals disabled by retinal vision loss could embark on a journey aboard a rocket that would restore their sight?

The Audacious Goals Initiative, established by the National Eye Institute in 2018, has made it a primary objective to conduct research aimed at creating such a groundbreaking “rocket” within the next 10 to 15 years by restoring vision through regeneration of the retina. Distinguished scientists from across the nation are joining forces, collaborating to push the boundaries of vision science.

A doctor on the phone examining images on a computer screen.
Jay Stewart, MD

With gifts over $2 million thus far, a team of four vision scientists from UCSF are co-leading five-year cross-disciplinary investigations to advance this federal initiative.

Their triumph, along with the success of the entire initiative, holds the potential to revolutionize treatment and outcomes for individuals diagnosed with macular degeneration, glaucoma, inherited retinal disorders, retinal detachments, and traumatic retinal injuries.
 

Developing new imaging tools

One of the multi-site teams, led by UCSF Ophthalmology Chair, Jacque Duncan, MD, in partnership with Jay Stewart, MD and Deepak Lamba, MBBS, PhD, is diligently working on developing new imaging tools capable of scrutinizing the eye with unparalleled precision. Collaborating with Austin Roorda, PhD (UC Berkeley), and Joseph Carroll, PhD (Medical College of Wisconsin), Dr. Duncan utilizes these advanced tools to record light-sensing cells in patients with healthy retinas. Then they compare the healthy retinas to retinas of those with degenerating cells caused by genetic mutations and patients with retinal detachment after surgical repair.

A man wearing glasses and a black sweater smiling at the camera.
Deepak Lamba, MBBS, PhD

Stem cell biologist Deepak Lamba, MBBS, PhD, and his team are actively engaged in creating research models that increasingly emulate macular characteristics and diseases. Dr. Duncan compares the structure and function of these experimental photoreceptor cells to the images of cells from her patients diagnosed with macular diseases and inherited retinal degeneration. The closer the resemblance between the two, the higher the credibility of the lab-generated model.

Additionally, Dr. Lamba collaborates with Dr. Carroll to evaluate the potential of these cells to integrate into a diseased retina for visual recovery.

One woman and one man working with scientific equipment in a laboratory.
Jacque Duncan, MD, using adaptive optics scanning laser ophthalmoscopy to study vision cells in a participant’s eyes.

In another facet of the research, glaucoma specialist Yvonne Ou, MD, co-leads an investigation to pinpoint biological factors that facilitate neural regeneration in the retina. After scientists from Indiana University, Legacy Devers Eye Institute, and Oregon Health and Science University have transplanted and

A woman smiling in a professional setting.
Yvonne Ou, MD

studied image-transmitting cells in the retina, Dr. Ou’s lab then reconstructs the anatomic circuitry of the transplanted cells to determine to what extent they have integrated within the retina affected by glaucoma.
 

Collaboration works

In addition to funding, the Audacious Goals Initiative fosters regular collaboration among all the research teams, enabling feedback, information sharing, and input from an advisory group. This collaborative approach has already proven fruitful. As Dr. Duncan states, “With this support, we can fine-tune our approaches mid-course, accelerating discovery. It’s unlike any other federal grant I’ve been awarded.”

All May See celebrates 50 years

With special honors to Stephen D. McLeod, MD, and Kathleen Rydar

After a two-year wait to celebrate the 50th anniversary of That Man May See/All May See and pay tribute to the contributions of Stephen D. McLeod, MD, former chair of UCSF Department of Ophthalmology, and Kathleen Rydar, President Emerita, All May See Foundation, the long-anticipated event took place on Thursday, December 1, 2022, at San Francisco’s Chase Center.

Over 150 distinguished guests including University of California and UCSF leadership, faculty, staff, donors, board members and friends united for a delightful cocktail reception, dinner, and live concert featuring Italian tenor Andrea Bocelli. In a heartwarming moment during the event, Michael V. Drake, MD, the 21st President of the University of California and ophthalmologist, surprised Dr. McLeod with the establishment of the Stephen D. McLeod, MD, Endowed Chair in Ophthalmology. Talmadge E. King, Jr., MD, Dean of the UCSF School of Medicine, proudly unveiled the Stephen D. McLeod, MD, Research and Equipment Fund. Dr. McLeod then presented President Emerita Kathleen Rydar with a certificate commemorating the Kathleen Rydar Inspiration Fund. This remarkable initiative has garnered more than $370,000 since its inception in 2020. The occasion also marked the warm welcome of Jacque Duncan, MD, as the new Chair of the Department of Ophthalmology, who was congratulated by All May See Foundation Board Chair John de Benedetti.

QR code with donation message on orange background.

The event’s impact extended beyond mere celebration, as it raised $230,000 for vision research. Earlier in the year, a group of 75 generous donors contribute Clinical Specialtiesed $1,040,000 to establish the McLeod Endowed Chair and also to create the research and equipment fund in honor of Dr. McLeod.
 

With special thanks

We extend sincere gratitude to Don and Judy McCubbin, as well as the Wayne and Gladys Valley Foundation, for their significant contributions as lead donors of the McLeod Endowed Chair. Other notable event sponsors included the Koret Foundation, John Hall and Rebecca Derrington, The Ron Conway Family, Mo and John Pritzker, Nancy and Sandy Robertson, Nancy Voorhees, Leftwich Event Specialists, Inc., and two anonymous donors.

On behalf of the Board of Directors and staff of All May See, we express our heartfelt appreciation to everyone for their overwhelming and generous support.


 

Photos from the 50th Celebration

Group of six professionals in formal attire at an event.
Ying Han, MD, PhD; Jacque Duncan, MD; Stephen D. McLeod, MD; Nisha Acharya, MD, MS; Neel Pasricha, MD; and, John Gonzales, MD
Two men shaking hands during an award presentation on stage.
Michael V. Drake, MD, President, University of California honors Stephen D. McLeod, MD
Smiling woman with curly hair in a blue shawl.
Honoree Kathleen Rydar, President Emerita, All May See Foundation
Man speaking into a microphone at an event.
John de Benedetti, All May See Foundation Board Chair
Five people smiling at a charity event.
Frank Brodie, MD, MBA; Julie Schallhorn, MD, MS; Julius Oatts, MD; Maanasa Indaram, MD; and, Neeti Parikh, MD
Three individuals posing for a photo in front of a foundation backdrop.
Aparna Lakkaraju, PhD; Talmadge E. King, Jr., MD; and, Nailyn Rasool, MD, FRCPC, FRCSC
Five people posing together at an event.
Stephen D. McLeod, MD; Elise McLeod; Thomas Lietman, MD, Chihori Lietman, MD; and, Marion Faymonville
Two women posing together at an event.
Susan Koret and Helen Kim
Two smiling individuals standing in front of a foundation banner.
Michael Desler and Margaret Desler, MD
Five men posing together at an event.
Xin Duan, PhD; Bryan J. Winn, MD; Reza Vagefi, MD; Jay M. Stewart, MD
Three professionals posing together at an event.
Barbara and Jeff Farber and All May See President, Deborah Chesky

A Shining Light for Cataract Patients

(above) Michael V. Drake, MD, President of the University of California with Daniel Schwartz, MD

Infographic about donation impact with QR code.

This past spring, a remarkable breakthrough in cataract technology brought renewed hope to patients seeking improved vision. All May See’s President Emerita, Kathleen Rydar, underwent cataract surgery at UCSF, where Associate Professor Julie Schallhorn, MD, MS, performed the procedure using an innovative Light Adjustable Lens™ (LAL). These groundbreaking lenses, developed by UCSF’s very own Daniel Schwartz, MD, in collaboration with Nobel Laureate, the late Robert Grubbs, PhD, and Julia Kornfield, PhD, from Caltech, revolutionize the post-surgery experience for patients by fine-tuning the visual correction using only ultraviolet light.

The origins of the LAL date back 25 years when Dr. Schwartz first envisioned the concept. As a retinal specialist, he was inspired to create an intraocular lens made of a light-sensitive material that could be adjusted non-invasively using a laser after the eye had healed and the refractive errorwas stable. This idea sparked a fruitful collaboration with Dr. Grubbs, leading to the realization of this groundbreaking technology. The U.S. Food and Drug Administration (FDA) approved the LAL in 2017, offering patients who had undergone cataract surgery the possibility of optimized vision without relying on glasses.

Close-up of a woman with light hair in a dark jacket.
Kathleen Rydar, All May See’s President Emerita

The All May See Foundation played a crucial role in supporting the initial efforts of the collaboration at Caltech, fostering the development of this extraordinary technology.
 

President Emerita receives light adjustable lenses

One of the first recipients of the LAL at UCSF, Ms. Rydar attests to its effectiveness, expressing her delight at the outcome. After three adjustment sessions, she can now read effortlessly and enjoy the beauty of the world, even spotting wildflowers on mountaintops without the aid of glasses.

A woman in a white coat smiling beside ophthalmology equipment.
Associate Professor, Julie Schallhorn, MD, MS

Dr. Schallhorn, who performed the surgery, emphasizes the significant impact the LAL has had on her surgical practice. While existing techniques for selecting intraocular lens power are highly effective, some patients still require glasses. With the light adjustable lens, the risk of such errors is substantially decreased. Patients can now experience clear vision without their cataract and fine-tune their eyesight to their exact preferences, marking a momentous advancement in post-cataract surgical care.

Dr. Schallhorn is enthusiastic about the future of ophthalmology, particularly with the continuous development of new technologies. Reflecting on the field’s progress over the past 50 years, she marvels at how cataract surgery has transformed from a procedure with significant risk of potential vision loss to a routine
outpatient surgery.

Dr. Schallhorn and her colleagues at UCSF, alongside other visionaries in the field, are committed to exploring new ways to treat vision impairment and continue pushing the boundaries
of ophthalmic innovation.

Text about Light Adjustable Lens innovations.

The Light Adjustable LensTM represents a shining beacon of hope for cataract patients, illuminating a future where clearer vision and improved quality of life are within reach for countless individuals around the world.

 

Lap for Landon: Extending UCSF Ophthalmology’s Impact Beyond the Bay Area

A family with a stroller at an outdoor event.
Brian Woods (dad), Courtney Woods (mom), Everett Woods (brother), and Landon Woods (in stroller)

FAMILY INITIATIVES

The impact of UCSF Ophthalmology reaches far beyond the Bay Area, as exemplified by a heartwarming tribute to Landon, a young boy diagnosed with Gould Syndrome, organized by his family from St. Louis, Missouri. Despite the pouring rain on October 30, 2022, more than 150 adults and children gathered to celebrate Landon’s first birthday through a Lap for Landon walk to raise awareness for his condition.

One-third of infants diagnosed with Gould Syndrome have cataracts or developmental defects leading to early-onset glaucoma. This rare, multisystem disorder named after Douglas Gould, PhD, Professor and Vice President for Research for UCSF Ophthalmology, honors his groundbreaking discovery and tireless research in this area.

The syndrome results from mutations in collagen genes COL4A1 and COL4A2 responsible for the support and reinforcement of body tissues.

The family’s effort contributed over $12,000 from the walk to support Dr. Gould’s vision research, aiming to make a lasting difference in treating this uncommon ailment.

Spreading the word proves fruitful

All May See has raised awareness and funds for Gould Syndrome for more than a year. Our journey began on Rare Disease Day 2022 with a generous $125,000 challenge gift from a Texas family whose 9-year-old son had recently been diagnosed with Gould Syndrome (featured in Vision Summer 2022). On Rare Disease Day and Gould Syndrome Day 2023, we issued a second challenge to reach $250,000 in donations. Through the kind contributions of individuals and families worldwide affected by Gould Syndrome, we have raised over $187,000.

The fund’s purpose is to gain a deeper understanding of the underlying mechanisms of Gould Syndrome. Dr. Gould’s lab is actively exploring therapeutic avenues, including the potential use of CRISPR gene-editing technology, which holds promise.

The St. Louis family is holding the Second Lap for Landon on Saturday, October 21st. To support this effort in honor of Landon and individuals affected world-wide, please visit the All May See Foundation donation page (allmaysee.org/donate) and select “Lap for Landon 2023” from the drop-down menu under “Designation.”